Avermectin B1a inhibits the binding of strychnine to the glycine receptor of rat spinal cord
- 1 April 1982
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 29 (2) , 173-176
- https://doi.org/10.1016/0304-3940(82)90349-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Solubilization of the glycine receptor from rat spinal cordBrain Research, 1981
- UV light-induced cross-linking of strychnine to the glycine receptor of rat spinal cord membranesBiochemical and Biophysical Research Communications, 1981
- GABA‐Benzodiazepine‐Barbiturate Receptor InteractionsJournal of Neurochemistry, 1981
- In Vitro Modulation by Avermectin B1a of the GABA/Benzodiazepine Receptor Complex of Rat CerebellumJournal of Neurochemistry, 1981
- Avermectin B1a: An irreversible activator of the γ-aminobutyric acid-benzodiazepine-chloride-ionophore receptor complexBiochemical and Biophysical Research Communications, 1980
- Stereospecific interaction of bicuculline with specific [3H]strychnine binding to rat spinal cord synaptosomal membranesNeuroscience Letters, 1980
- Enhancement of in vitro binding and some of the pharmacological properties of diazepam by a novel anthelmintic agent, avermectin B1aEuropean Journal of Pharmacology, 1979
- Avermectin B1a irreversibly blocks postsynaptic potentials at the lobster neuromuscular junction by reducing muscle membrane resistance.Proceedings of the National Academy of Sciences, 1979
- The hyperpolarization of spinal motoneurones by glycine and related amino acidsExperimental Brain Research, 1968